JAMA Network Home
Sign In
Research Letter

GLP-1 Receptor Agonist Prescriptions Among People With and Without Serious Mental Illness

JAMA Psychiatry 10.1001/jamapsychiatry.2026.2667

September 02, 2026 at 11:00 AM EDT

Read the full article

This cross-sectional study examines glucagon-like peptide-1 (GLP-1) prescriptions among adults with vs without severe mental illness from 2018 to 2024 using national insurance claims.

Corresponding Author: Emma E. McGinty, PhD, MS, Population Health Sciences, Weill Cornell Medicine, 575 Lexington Ave, Office 655B, New York, NY 10022 (emm4010@med.cornell.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2026.2667?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090226

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks